Trials / Terminated
TerminatedNCT05240560
Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke
A Multisite Randomized Clinical Trial Evaluating Efficacy and Safety of BP1.3656 vs Placebo in Patients With Fatigue Following Ischemic Stroke
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Bioprojet · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, randomized, double blind, parallel-group, placebo-controlled proof of concept study evaluating efficacy and safety of BP1.3656 in patients with fatigue following ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BP1.3656 | Histamine H3 receptor antagonist/inverse agonist |
Timeline
- Start date
- 2023-01-20
- Primary completion
- 2024-02-08
- Completion
- 2024-02-08
- First posted
- 2022-02-15
- Last updated
- 2024-08-09
Locations
2 sites across 2 countries: France, Switzerland
Source: ClinicalTrials.gov record NCT05240560. Inclusion in this directory is not an endorsement.